Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

September 30, 2020September 30, 2020

TransCon PTH Reduces Need for Other Therapy, Improves Quality of Life, New Data Show

News

Ascendis Pharma‘s TransCon PTH can safely treat hypoparathyroidism, reducing the need for other therapies and improving patients’ quality of life, an extension period of the PaTH Forward Phase 2 ... Read more

September 9, 2020September 9, 2020

TransCon PTH Safe, Effective, May Reduce Need for Other Therapies, Trial Data Shows

News

TransCon PTH, an investigational therapy being developed by Ascendis Pharma, safely normalized calcium and phosphate levels, and reduced the need for other treatments in adults with hypoparathyroidism, data from ... Read more

September 2, 2020September 2, 2020

Stem Cells Production Method Could Lead to New Therapies, Study Suggests

News

A novel approach for the production of parathyroid-like cells from stem cells — cells from which all others with specialized functions are generated — could help find new treatments ... Read more

July 8, 2020July 8, 2020

ProLynx Awarded NIH Grant to Develop Long-acting PTH Therapy

News

ProLynx has been awarded a small business innovation research grant from the National Institutes of Health (NIH) to develop its long-acting parathyroid hormone (PTH) therapy — known as PTH(1-34) — ... Read more

June 17, 2020June 17, 2020

Alizé Pharma 3 Rebrands as Amolyt Pharma, Plans AZP-3601 Trial

News

Alizé Pharma 3 is rebranding as Amolyt Pharma and plans to start clinical testing of a potential hypoparathyroidism treatment known as AZP-3601 later this year. “Our new name, Amolyt Pharma, ... Read more

May 6, 2020May 6, 2020

Calcific Tendonitis May Be Complication of Hypoparathyroidism

News

People with hypoparathyroidism may be at risk of having calcium crystals form in their tendons — a condition called calcific tendonitis — which can cause joint pain and inflammation, a ... Read more

April 15, 2020April 15, 2020

Supplement Need After Thyroid Cancer Surgery Linked to Poorer Life Quality

News

People needing to take vitamin D and calcium supplements due to very low levels soon after thyroid cancer surgery are likely to experience a decline in their quality of ... Read more

January 29, 2020January 29, 2020

High Rate of Calcium-alkali Syndrome Linked to Post-surgery Hypoparathyroidism, Study Suggests

News

People with hypoparathyroidism after surgical removal of the thyroid may develop calcium-alkali syndrome (CAS) — particularly if they are given high doses of vitamin D as a part of ... Read more

December 18, 2019December 18, 2019

Low PTH Levels May Lead to Greater Risk of Fractures in Hypoparathyroidism, Study Suggests

News

Lower levels of parathyroid hormone (PTH) in people with hypoparathyroidism may lead to decreased bone material strength and increase the risk of fractures, a new study reports. The study, ... Read more

November 20, 2019April 22, 2020

Phase 2 Trial of TransCon PTH to Speed Enrollment of Patients Affected by U.S. Recall of Natpara

News

A Phase 2 trial testing the experimental therapy TransCon PTH in adults with hypoparathyroidism is expanding to allow for faster enrollment of people previously treated with Natpara (parathyroid hormone, ... Read more

Pin It on Pinterest